E
CNST

Ergoteles’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Ergoteles’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-280,900
Closed -$9.49M – 1880
2021
Q2 		$9.49M Buy
+280,900
New +$7.16M 0.22% 140

Ergoteles's CNST Position: Q3 2021 in Review

Ergoteles sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 280,900 shares — an estimated $9.49M sold.

Ergoteles first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $9.49M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Ergoteles reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Ergoteles sold 280,900 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $9.49M.
  • Ergoteles first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Ergoteles's Constellation Pharmaceuticals, Inc. position peaked at $9.49M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.